A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
Teva Pharmaceutical Industries
This study is designed to compare injection skin (injection site) reactions when an
antihistamine (Zyrtec®) or placebo is taken prior to performing daily Copaxone® injections.
Patients will be assigned (like a flip of a coin) to take either a placebo or an
antihistamine (Zyrtec®) prior to performing their daily Copaxone® injections. The patient
and physician will be unaware whether they are taking a placebo or antihistamine during the
Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema
Korean double-blind non-inferiority study to asses the efficacy (as measured by the
responder rate of pruritus severity score by the patient at visit 4 or end-of-treatment
visit over the 2 weeks treatment period) and safety of Xyzal® to Zyrtec® in subjects
suffering from dermatitis and eczema with pruritus symptoms
A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber
Faes Farma, S.A.
This is a randomized, double blind, active and placebo controlled, 4 way crossover study in
patients with seasonal allergic rhinitis. Patients will receive a single dose of bilastine
20 mg, Cetirizine 10 mg, Fexofenadine 120 mg, and placebo in the Vienna Challenge Chamber.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.